Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
crispr
3
×
editas medicine
gene editing
3
×
life sciences
national blog main
allergan
boston
clinical trials
cynthia collins
katrine bosley
san francisco blog main
abbvie
advaxis
aimmune therapeutics
alder biopharmaceuticals
alexander hardy
alzheimer's disease
andrew oxtoby
babies
boulder/denver blog main
boulder/denver top stories
breakup
bridge bio pharma
ceo
clinical hold
clinical study
combination
commissioner
congress
crispr-cas9
deals
delisting
democrats
departure
detroit blog main
detroit top stories
drug pricing
What
editas
3
×
ceo
crispr
editing
experimental
gene
katrine
medicine
abbvie
allergan
alliance
big
bio
biotech
blessing
bosley
bosley's
bosley’s
bridge
bucks
cas
check
clinical
crime
cusp
depart
departure
exit
exits
genetic
guiding
humans
medicines
million
moves
pact
partner
partnership
personnel
pruning
Language
unset
Current search:
crispr
×
editas
×
" gene editing "
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial